Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.

Pharmaceutical

Sygnature Discovery Limited

Simon Hirst

Alex Stevens

David Witty

Indranil Duttagupta

Hannah Warren

Clare Wilson

Charlotte Criscuolo

Martin Lau Christiansen

Katarzyna Kopycka

James Engleback

Dr. Gopi Krishna Reddy Alavala

Arundhati Dongre

Aparna Chandrasekaran

Amy Cantrell

Amelia Taibon-Kuer

Jack Hardy

Claire Ellis-Ross

Emily Eaton

Dave Pearson

John Unitt

Max Mirza

Allan Jordan

Stuart Onions

Jane Kendrew

Colin Sambrook Smith

James Edgar

Geraint Jones

Jonathan Williams

Paul Overton

Stephen Young

Louisa Jordison

The Scientists Team at Sygnature Discovery Limited conducts advanced drug discovery research incorporating a wide range of therapeutic and biological target classes. They specialize in areas such as Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, and DMPK, leveraging their expertise to develop innovative solutions and support the company's comprehensive drug discovery projects.

Scientists Team

Leadership Team

Discovery and Drug Development

Scientists Team

About

Team members

Other teams at Sygnature Discovery Limited

Leadership Team

Discovery and Drug Development